Business Description
GlobeStar Therapeutics Corp
NAICS : 325412
SIC : 2834
ISIN : US03476L1026
Description
GlobeStar Therapeutics Corp is a clinical-stage Pharmaceutical Company introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is focused on developing therapies for people with serious and life-threatening rare disorders.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Debt-to-Equity | -0.24 | |||||
| Debt-to-EBITDA | -0.2 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -26 | |||||
| 3-Year Book Growth Rate | 20.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.53 | |||||
| 9-Day RSI | 45.8 | |||||
| 14-Day RSI | 43.61 | |||||
| 6-1 Month Momentum % | 10.53 | |||||
| 12-1 Month Momentum % | -63.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -31.7 | |||||
| Shareholder Yield % | -30.02 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.76 | |||||
| EV-to-EBITDA | -0.76 | |||||
| EV-to-FCF | -6.74 | |||||
| Earnings Yield (Greenblatt) % | -131.58 | |||||
| FCF Yield % | -20.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:GSTC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GlobeStar Therapeutics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.002 | ||
| Beta | 1.57 | ||
| Volatility % | 112.56 | ||
| 14-Day RSI | 43.61 | ||
| 14-Day ATR ($) | 0.00019 | ||
| 20-Day SMA ($) | 0.000841 | ||
| 12-1 Month Momentum % | -63.48 | ||
| 52-Week Range ($) | 0.0006 - 0.00815 | ||
| Shares Outstanding (Mil) | 1,162.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GlobeStar Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GlobeStar Therapeutics Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
GlobeStar Therapeutics Corp Frequently Asked Questions
What is GlobeStar Therapeutics Corp(GSTC)'s stock price today?
The current price of GSTC is $0.00. The 52 week high of GSTC is $0.01 and 52 week low is $0.00.
When is next earnings date of GlobeStar Therapeutics Corp(GSTC)?
The next earnings date of GlobeStar Therapeutics Corp(GSTC) is .
Does GlobeStar Therapeutics Corp(GSTC) pay dividends? If so, how much?
GlobeStar Therapeutics Corp(GSTC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers